United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir ointment, 5% is indicated in the management of initial genital herpes and in limited non-life-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients. acyclovir ointment, 5% is contraindicated in patients who develop hypersensitivity to the components of the formulation.

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - ketoconazole (unii: r9400w927i) (ketoconazole - unii:r9400w927i) - ketoconazole shampoo, 2%, is indicated for the treatment of tinea (pityriasis) versicolor caused by or presumed to be caused by pityrosporum orbiculare (also known as malassezia furfur or m. orbiculare ). note: tinea (pityriasis) versicolor may give rise to hyperpigmented or hypopigmented patches on the trunk which may extend to the neck, arms and upper thighs. treatment of the infection may not immediately result in normalization of pigment to the affected sites. normalization of pigment following successful therapy is variable and may take months, depending on individual skin type and incidental sun exposure. although tinea versicolor is not contagious, it may recur because the organism that causes the disease is part of the normal skin flora. ketoconazole shampoo, 2%, is contraindicated in persons who have known hypersensitivity to the active ingredient or excipients of this formulation.

United States - English - NLM (National Library of Medicine)

advanced rx pharmacy of tennessee, llc - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium gel, 3% is indicated for the topical treatment of actinic keratoses (ak). sun avoidance is indicated during therapy. diclofenac sodium gel, 3% is contraindicated in patients with a known hypersensitivity to diclofenac, benzyl alcohol and/or polyethylene glycol monomethyl ether 350. diclofenac sodium gel, 3% is contraindicated in the following patients: - in the setting of coronary artery bypass graft (cabg) surgery.

Philippines - English - FDA (Food And Drug Administration)

astellas pharma philippines, inc.; distributor: zuellig pharma corporation - leuprorelin acetate - lyophilized solution for injection (s.c.) - 7.5mg

Philippines - English - FDA (Food And Drug Administration)

astellas pharma philippines, inc.; distributor: zuellig pharma corporation - leuprorelin acetate - lyophilized powder for injection - 22.5mg

Philippines - English - FDA (Food And Drug Administration)

astellas pharma philippines, inc.; distributor: zuellig pharma corporation - leuprorelin acetate - lyophilized solution for injection (s.c.) - 45mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

astellas pharma, netherlands - leuprorelin - powder and solvent for solution for injection - 7.5 mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

astellas pharma, netherlands - leuprorelin - powder and solvent for solution for injection - 22.5 mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

astellas pharma, netherlands - leuprorelin - powder and solvent for solution for injection - 45 mg

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

lunatus drug store llc united states of america - 1's (1 pre-filled syringe a + 1 pre-filled syringe b) - injection - 22.5mg - malignant disease,immunosuppresion-sex hormones , antagonists in malignant diseas